Key result
AMNRAS risk score shows high accuracy for noncommunicable diseases with an AUC of ~0.83.
Case-Control (n=84)
Answers are grounded in this paper and cite their sources.
BACKGROUND: Globally Noncommunicable Diseases is lead causes of mortality. This calls for the need of sensitive and cost appropriate screening tools to identify asymptomatic healthy individuals with higher risk and/or subclinical NCD in the community. The study aims to generate pilot evidence based, validated, good quality, cost appropriate, and sustainable risk assessment score for NCD for developing countries like India. METHODS: This descriptive retrospective study of diabetic camp data of 84 patients was conducted. A risk score having 10 questions and three measurements for NCDs appropriate for Indian communities was generated. It was compared to IDRS, FINDRISC, FRS, CBAC, and WHO/ISH prediction charts. RESULTS: The study finally included 36 patients with NCD as case and 44 subjects without NCD as control. The means of weight, waist circumference, blood pressure, and blood sugar were significantly different among the two groups. AMNRAS of more than 14 was highly predictive for an individual to be at risk of NCD or sub clinical case of NCD requiring evaluation. The proposed cut-off of 8 for AMNRAS, the sensitivity and NPV was highest compared to other score, 88.9% and 84.6%, respectively. Score for the Area under curve was significantly higher for AMNRAS [0.83 (0.74 to 0.92)] compared to other scores. CONCLUSIONS: AMNRAS has higher performance parameters than the other five tested in the present study. Other scoring system performs only modestly in discrimination of NCD cases. The accuracy of AMNRAS for NCD risk will have to be determined in large size cohorts.
No takes yet. Share an insight, caveat, or question.
Gupta et al. (2021) conducted a case-control in Noncommunicable Diseases (n=84). AMNRAS (Noncommunicable Disease Risk Assessment Score) vs. Other risk scores (IDRS, FINDRISC, FRS, CBAC, WHO/ISH prediction charts) was evaluated on Discrimination of NCD cases (Area Under Curve) (AUC 0.83, 95% CI 0.74-0.92). The AMNRAS risk score demonstrated higher discriminatory accuracy for noncommunicable diseases than other established scores, with an area under the curve of 0.83.
Synapse has enriched 10 related papers. Consider them for comparative context: